Search hospitals > Louisiana > Shreveport
Louisiana Research Center, LLC
Claim this profileShreveport, Louisiana 71105
Global Leader in Crohn's Disease
Global Leader in Inflammatory Bowel Disease
Conducts research for Ulcerative Colitis
Conducts research for Ulcer
Conducts research for Non-alcoholic Fatty Liver Disease
95 reported clinical trials
2 medical researchers
Summary
Louisiana Research Center, LLC is a medical facility located in Shreveport, Louisiana. This center is recognized for care of Crohn's Disease, Inflammatory Bowel Disease, Ulcerative Colitis, Ulcer, Non-alcoholic Fatty Liver Disease and other specialties. Louisiana Research Center, LLC is involved with conducting 95 clinical trials across 63 conditions. There are 2 research doctors associated with this hospital, such as Humberto I. Aguilar and Arthur Poch, MD.Top PIs
Humberto I. AguilarLouisiana Research Center, LLC3 years of reported clinical research
Studies Colorectal Cancer
Studies Crohn's Disease
9 reported clinical trials
13 drugs studied
Arthur Poch, MDLouisiana Research Center, LLC16 years of reported clinical research
Studies Irritable Bowel Syndrome
Studies Syndrome
1 reported clinical trial
1 drug studied
Clinical Trials running at Louisiana Research Center, LLC
Liver Cirrhosis
Ulcerative Colitis
Nonalcoholic Steatohepatitis
Cholangitis
Primary Biliary Cirrhosis
Non-alcoholic Fatty Liver Disease
Fatty Liver Disease
Obesity
Crohn's Disease
Inflammatory Bowel Disease
Resmetirom
for NASH Cirrhosis
This trial tests a daily pill called resmetirom for people with a stable form of liver disease not caused by alcohol. The goal is to see if the drug can improve liver function and reduce liver fat, thereby preventing serious complications. Resmetirom has been tested in previous studies for the treatment of liver disease.
Recruiting1 award Phase 39 criteria
Elafibranor
for Primary Biliary Cholangitis
This trial is testing elafibranor, a medication for people with Primary Biliary Cholangitis (PBC) who do not respond to or cannot take the usual treatment. PBC is a liver disease that can lead to severe damage if untreated. Elafibranor aims to reduce harmful substances in the liver to prevent further damage. The study will also check if the medication is safe and helps with symptoms like itching and tiredness. Elafibranor is being tested as a new treatment option for PBC patients who do not respond to or cannot tolerate the standard treatments.
Recruiting1 award Phase 36 criteria
Seladelpar
for Primary Biliary Cholangitis
To Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects with Primary Biliary Cholangitis (PBC) and an Incomplete Response or Intolerance to Ursodeoxycholic Acid (UDCA)
Recruiting1 award Phase 35 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Louisiana Research Center, LLC?
Louisiana Research Center, LLC is a medical facility located in Shreveport, Louisiana. This center is recognized for care of Crohn's Disease, Inflammatory Bowel Disease, Ulcerative Colitis, Ulcer, Non-alcoholic Fatty Liver Disease and other specialties. Louisiana Research Center, LLC is involved with conducting 95 clinical trials across 63 conditions. There are 2 research doctors associated with this hospital, such as Humberto I. Aguilar and Arthur Poch, MD.